Not finding the right medicine? We can help
Verzenio/Verzenios (abemaciclib)
We can help with your prescription. Read the “Prescription Guide”.
You can access this medicine even if it's not approved in your country. Learn how.
Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer.
Disease Indications
Breast Cancer
Manufacturer
Lilly
Usage
Oral
Medicine approved by
-
European Medical Agency (EMA)
-
Food and Drug Administration (FDA)
-
Health Canada
-
Therapeutic Goods Administration (TGA)
Patients helped
- Over 1.2 million patients reached
- More than 11,000 patients helped
- 100% successful deliveries to 88 countries
We can help with your import documents
We are experts in import regulations. Scroll below to download the import guide for your country.
FREQUENTLY ASKED QUESTIONS
We help you access approved medicines that are not approved or available in your country of residence.
Legal
We help you access approved medicines that are not approved or available in your country of residence.
Legal
Finances
Payment
- Your permanent residence is outside the European Union
- You take the medicines with you, unused within 90 days after purchase
- You have a full original receipt (which we provide you)
Unfortunately, we are unable to help with VAT refunds following delivery or collection from our partner pharmacies outside of the Netherlands.
- If you are residing within the European Union and you are not a company
- If you are coming to Amsterdam, Luxembourg or Dusseldorf to pick up your order
In case of pick up, you may be eligible for a VAT tax refund if you live outside the European Union.
Price
Reimbursement
- That you want to import an approved medicine from abroad
- The lack of reasonable treatment options available in your country (if you can, include a letter from a doctor confirming this) - no alternative to the treatment.
- That the medicine has already been approved in another country (state the name of the country)
- That your treating doctor states that this medicine is the best option for you (include a copy of the prescription in the letter to the healthcare insurance company)
Ordering and shipping
Ordering
- Name of the patient
- Contact details of patient(email and phone number)
- Copy of patient’s ID
- Contact details of the Doctor (name, address, email and phone number)
- Shipping address
- Copy of the doctor's prescription
Shipping: We can deliver to the patient's residence, a pharmacy, or doctor's office / hospital, but this depends on the country. If you’re not sure what the right choice is for you, please get in touch with our Patient Support Team and we can help you work out your exact requirements.
Once we have received this information, one of our Patient Support Team members will then check your prescription and contact you to follow up on your order. Please note that other documents may be needed for import, we will guide you through the ordering process.
Generally not, but we do provide you with an invoice after you make the payment that you may send to your medical insurance company so they can reimburse you. In some limited circumstances, we do accept insurance. Contact us for more details.
As part of our protocols we might reach out to your treating doctor for verification or information updates. By sending us your prescription you allow us to do so.
- Patient's name and date of birth
- Name of the medicine and dosage
- Required quantity
- Doctor's name and signature
- Doctor's registration number and/or stamp
Ideally, the prescription should be issued in English. Alternatively, a translation (unofficial is sufficient) must be provided.
Please be aware that your doctor may be contacted by one of our team members or by the processing pharmacy in order to verify the prescription.
Shipping
Please be aware that due to the COVID-19 situation worldwide and the country lockdowns, we will sometimes experience delays in shipping.
For EMA approved medicines with prescriptions from within the Schengen zone, you can pick the medicines up from our partner pharmacy in Amsterdam, Luxembourg or Dusseldorf. For non-EMA approved medicines, with prescriptions from within the Schengen zone, you can pick the medicines up in our partner pharmacy in Dusseldorf. If you have requested to collect your medicines, you will receive a notification when the medicines are in the pharmacy and ready for you.
There are also options to deliver the medicines to other countries. Please get in touch with our Patient Support Team to discuss which other pick-up and delivery options may be suitable for you.
- Copy of the ID/passport of the patient
- Copy of the ID/passport of the person who is coming to pick up the medicines
- Letter signed by the patient stating that he/she authorises this person to pick up the medicines on his/her behalf
- Step 1 - Customs may need to check the package to verify its contents. In order to streamline this step, we include a letter for customs with information about the contents. Any additional questions will be answered by everyone.org as and when we are contacted by customs.
- Step 2 - In some countries, there are additional questions from the medical regulatory agencies (i.e. the FDA, EMA, etc). We provide them with all the necessary information based on the information provided by the patient, such as: the prescription, copy of ID and a letter from the treating doctor to show that the medicines are for personal use.
- Step 3 - Customs fees. In some cases, the recipient will be requested to pay taxes and duties. These should be arranged by the patient or receiver and are not covered by everyone.org unless stated otherwise.
Please be aware that the import of the medicines always requires customs clearance and active cooperation from the importing party. We will help and guide you but are dependent on your cooperation and responsiveness.
About us
- Complete the enquiry form on our Contact Us page
- Send an email: [email protected]
- Call us on:
- +31 20 808 4414 (EU)
- +1 646 381 0675 (US)
- +61 28 417 2910 (AUS)
Others
Available medicines
Medicine approval
The respective national and regional agencies, such as the Food and Drugs Administration (FDA) in the USA or the European Medical Authority (EMA) for the European Union assess these applications and make a decision on whether to approve new medicines. The review process is based on evaluation of the evidence provided by the company. Every agency uses a slightly different process.
- Phase I - performed in a small number of healthy volunteers or very sick patients with lack of treatment options, designed to study the effects of the medicine in the human body.
- Phase II - larger number of patients, designed to evaluate the safety and efficacy of the medicine and to determine if different dosages of the treatment have different effects.
- Phase III - large number of patient groups, designed to confirm the safety and efficacy of the medicine.
- Phase IV - after the medicine has received regulatory approval, designed to evaluate the long-term effects.
Updates
Finances
Payment
- Your permanent residence is outside the European Union
- You take the medicines with you, unused within 90 days after purchase
- You have a full original receipt (which we provide you)
Unfortunately, we are unable to help with VAT refunds following delivery or collection from our partner pharmacies outside of the Netherlands.
- If you are residing within the European Union and you are not a company
- If you are coming to Amsterdam, Luxembourg or Dusseldorf to pick up your order
In case of pick up, you may be eligible for a VAT tax refund if you live outside the European Union.
Price
Reimbursement
- That you want to import an approved medicine from abroad
- The lack of reasonable treatment options available in your country (if you can, include a letter from a doctor confirming this) - no alternative to the treatment.
- That the medicine has already been approved in another country (state the name of the country)
- That your treating doctor states that this medicine is the best option for you (include a copy of the prescription in the letter to the healthcare insurance company)
Ordering and shipping
Ordering
- Name of the patient
- Contact details of patient(email and phone number)
- Copy of patient’s ID
- Contact details of the Doctor (name, address, email and phone number)
- Shipping address
- Copy of the doctor's prescription
Shipping: We can deliver to the patient's residence, a pharmacy, or doctor's office / hospital, but this depends on the country. If you’re not sure what the right choice is for you, please get in touch with our Patient Support Team and we can help you work out your exact requirements.
Once we have received this information, one of our Patient Support Team members will then check your prescription and contact you to follow up on your order. Please note that other documents may be needed for import, we will guide you through the ordering process.
Generally not, but we do provide you with an invoice after you make the payment that you may send to your medical insurance company so they can reimburse you. In some limited circumstances, we do accept insurance. Contact us for more details.
As part of our protocols we might reach out to your treating doctor for verification or information updates. By sending us your prescription you allow us to do so.
- Patient's name and date of birth
- Name of the medicine and dosage
- Required quantity
- Doctor's name and signature
- Doctor's registration number and/or stamp
Ideally, the prescription should be issued in English. Alternatively, a translation (unofficial is sufficient) must be provided.
Please be aware that your doctor may be contacted by one of our team members or by the processing pharmacy in order to verify the prescription.
Shipping
Please be aware that due to the COVID-19 situation worldwide and the country lockdowns, we will sometimes experience delays in shipping.
For EMA approved medicines with prescriptions from within the Schengen zone, you can pick the medicines up from our partner pharmacy in Amsterdam, Luxembourg or Dusseldorf. For non-EMA approved medicines, with prescriptions from within the Schengen zone, you can pick the medicines up in our partner pharmacy in Dusseldorf. If you have requested to collect your medicines, you will receive a notification when the medicines are in the pharmacy and ready for you.
There are also options to deliver the medicines to other countries. Please get in touch with our Patient Support Team to discuss which other pick-up and delivery options may be suitable for you.
- Copy of the ID/passport of the patient
- Copy of the ID/passport of the person who is coming to pick up the medicines
- Letter signed by the patient stating that he/she authorises this person to pick up the medicines on his/her behalf
- Step 1 - Customs may need to check the package to verify its contents. In order to streamline this step, we include a letter for customs with information about the contents. Any additional questions will be answered by everyone.org as and when we are contacted by customs.
- Step 2 - In some countries, there are additional questions from the medical regulatory agencies (i.e. the FDA, EMA, etc). We provide them with all the necessary information based on the information provided by the patient, such as: the prescription, copy of ID and a letter from the treating doctor to show that the medicines are for personal use.
- Step 3 - Customs fees. In some cases, the recipient will be requested to pay taxes and duties. These should be arranged by the patient or receiver and are not covered by everyone.org unless stated otherwise.
Please be aware that the import of the medicines always requires customs clearance and active cooperation from the importing party. We will help and guide you but are dependent on your cooperation and responsiveness.
About us
- Complete the enquiry form on our Contact Us page
- Send an email: [email protected]
- Call us on:
- +31 20 808 4414 (EU)
- +1 646 381 0675 (US)
- +61 28 417 2910 (AUS)
Others
Available medicines
Medicine approval
The respective national and regional agencies, such as the Food and Drugs Administration (FDA) in the USA or the European Medical Authority (EMA) for the European Union assess these applications and make a decision on whether to approve new medicines. The review process is based on evaluation of the evidence provided by the company. Every agency uses a slightly different process.
- Phase I - performed in a small number of healthy volunteers or very sick patients with lack of treatment options, designed to study the effects of the medicine in the human body.
- Phase II - larger number of patients, designed to evaluate the safety and efficacy of the medicine and to determine if different dosages of the treatment have different effects.
- Phase III - large number of patient groups, designed to confirm the safety and efficacy of the medicine.
- Phase IV - after the medicine has received regulatory approval, designed to evaluate the long-term effects.
Updates
Verzenio/Verzenios (abemaciclib)
Package
Tablets
Where can we deliver?
We have delivered medicines to more than 88 countries. Check if we have sent medicines to yours.
We currently can’t ship medicines to - contact us for alternative options.
Make an enquiry to receive information about the different options of obtaining for a patient in .
We haven’t shipped medicines to yet. You can count on us to make it happen.
Make an enquiry to receive information about the cost, shipping time and import details for .
Yes, we have successfully delivered medicines to .
Make an enquiry to receive information about the cost, shipping time and import details for .
PICK-UP IN PERSON FROM A PARTNER PHARMACY
We can arrange for you to pick up this medicine from our partner pharmacy in Luxembourg. Read more.
Pick-up from Luxembourg.
Depending on your particular circumstance, this option can be cheaper and require less paperwork than direct delivery. You can ask someone else to pick up the medicine on your behalf.
In some cases, medicines can be picked up from partner pharmacies in Amsterdam (the Netherlands) or Dusseldorf (Germany).
Tell our Patient Support Team if you’re interested in pick-up options for your order.
GDP compliant. View certificate.
Licensed wholesale distributor. View certificate.
What is Verzenio (abemaciclib)?
Verzenio (abemaciclib) is a kinase inhibitor indicated to treat HR+/HER2 (hormone receptor positive/human epidermal growth factor receptor 2 negative) metastatic breast cancer1. It is also used for the treatment of postmenopausal women whose cancer has progressed after hormonal therapy or chemotherapy1.
Who is Verzenio (abemaciclib) for?
Verzenio (abemaciclib) is for patients with a type of breast cancer called HR+/HER2 (hormone receptor positive/human epidermal growth factor receptor 2 negative)1:
- as initial endocrine-based therapy in combination with an aromatase inhibitor for the treatment of postmenopausal women
- in women whose disease has progressed after hormonal therapy, in combination with fulvestrant
- in women whose disease has progressed after hormone therapy and prior chemotherapy as a monotherapy (not in combination with other medicines).
- for the adjuvant treatment of early breast cancer (EBC) at high risk of recurrence and a Ki-67 score of ≥20%
How does Verzenio (abemaciclib) work?
Verzenio is in a class of drugs known as CDK4 & 6 inhibitors2. CDK4 & 6 proteins control how fast cells grow and divide. CDK4 & 6 proteins are found in both normal and cancer cells2. They are overactive in patients with metastatic breast cancer, causing cells to grow and divide uncontrollably2. This leads to the spread of cancer2.
Verzenio works to stop these proteins and cells as they are moving to grow and divide2. It slows down the cell growth and division, which causes cancer cells to become inactive or even die. In preclinical studies, continuous exposure to Verzenio slowed down CDK4 & 6 proteins, which delayed cancer cells from growing and dividing2.
Where has Verzenio (abemaciclib) been approved?
Verzenio (abemaciclib) was approved for the treatment of patients with metastatic breast cancer by:
- Food and Drug Administration (FDA), USA:
- September 28, 20174, as second-line treatment
-
February 26, 20182,3, as first-line treatment.
- October 13, 2021 for the adjuvant treatment of EBC.
-
European Medical Agency (EMA), European Union, September 27, 20185
-
Health Canada, April 4, 20196
-
Therapeutic Goods Administration (TGA, under the Australia-Canada-Singapore-Switzerland [ACSS] Consortium's New Chemical Entities Work Sharing Initiative), Australia, April 9, 20197
Please note that this medicine may have also been approved in other regions than the ones we’ve listed. If you have a question about its approval in a specific country feel free to contact our support team.
How is Verzenio (abemaciclib) taken?
Verzenio (abemaciclib) is a tablet that is taken orally, with or without food1. The standard dosage is:
- 150 mg twice daily as a starting dose in combination with fulvestrant1
- 200 mg twice daily as a starting dose as monotherapy1
Dosing interruption and/or dose reductions may be required based on individual safety and tolerability1.
Warning:
-
Patients who experience diarrhea should alert their healthcare provider, initiate antidiarrheal therapy, and increase oral fluids1.
-
A patient’s blood counts should also be monitored prior to the start of Verzenio (abemaciclib) therapy, every 2 weeks for the first 2 months, monthly for the next 2 months, and as clinically indicated1.
-
Increases in serum transaminase (liver enzymes) levels have been observed in patients taking Verzenio (abemaciclib). Liver function tests (LFTs) should be performed before initiating treatment. LFTs should be monitored every two weeks for the first two months, monthly for the next 2 months, and as clinically indicated1.
-
Patients should be monitored for signs and symptoms of thrombosis and pulmonary embolism and treat as medically appropriate1.
Complete information about Verzenio (abemaciclib) dosage and administration can be found in the official prescribing information listed in our references section1.
Note: Please consult with your treating doctor for personalised dosing.
Are there any known side effects or adverse reactions of Verzenio (abemaciclib)?
Common adverse reactions
The most common adverse reactions listed in the prescribing information include1:
- diarrhea
- neutropenia
- nausea
- abdominal pain
- infections
- fatigue
- anemia
- leukopenia
- decreased appetite
- vomiting
- headache
- thrombocytopenia
Serious adverse reactions
The serious adverse reactions listed in the prescribing information include1:
- diarrhea
- alterations in a patient’s blood counts
- increases in liver enzymes
- thrombosis and pulmonary embolism
Use in specific populations
- Pregnant women: Verzenio (abemaciclib) can cause fetal harm when administered to a pregnant woman, it is advised to avoid pregnancies and breast feeding1.
- Breastfeeding women: There are no data on the presence of abemaciclib in human milk, or its effects on the breastfed child or on milk production1. Because of the potential for serious adverse reactions in breastfed infants, it’s advised that lactating women do not breastfeed during treatment and for at least 3 weeks after the last dose1.
- Women with reproductive potential: Verzenio (abemaciclib) can cause fetal harm when administered to a pregnant woman Pregnancy testing is recommended for females of reproductive potential prior to initiating treatment with Verzenio (abemaciclib)1. Women who could possibly become pregnant (have reproductive potential) should be advised to use effective contraception during treatment and for at least 3 weeks after the last dose1.
- Men: Based on findings in animals, Verzenio (abemaciclib) may impair fertility in males of reproductive potential1.
- Pediatric use (children): The safety and effectiveness of Verzenio (abemaciclib) have not been established in children1.
- Geriatric patients (elderly patients): Of the 441 patients who received Verzenio (abemaciclib) in the MONARCH 2 trial, 35% were 65 years of age or older and 9% were 75 years of age or older. Of the 132 patients who received Verzenio (abemaciclib) in MONARCH 1, 32% were 65 years of age or older and 8% were 75 years of age or older. No overall differences in safety or effectiveness of Verzenio (abemaciclib) were observed between older patients and younger patients1.
- Renal impairment (kidney problems): No dosage adjustment is required for patients with mild or moderate renal impairment1.
- Hepatic impairment (liver problems): No dosage adjustments are necessary in patients with mild or moderate hepatic impairment (Child-Pugh A or B). Reduce the dosing frequency when administering Verzenio (abemaciclib) to patients with severe hepatic impairment (Child-Pugh C)1.
For a comprehensive list of side effects and adverse reactions please refer to the official prescribing information1
References
1. Highlights of Prescribing Information: Verzenio:(abemaciclib).
Eli Lilly and Company. February 2018
2. Verzenio.com
Cited 20/06/2018
3. FDA press release: FDA approves abemaciclib as initial therapy for HR-positive, HER2-negative metastatic breast cancer.
(Last Updated: 02/26/2018) Cited 20/06/2018
4. FDA press release: FDA approves new treatment for certain advanced or metastatic breast cancers.
(Last update: 28/09/2017), cited on 25/06/2018
5. Summary of Product Characteristics [EMA]: Verzenios (abemaciclib) [PDF]
September 2018
6. Summary of Product Characteristics [Health Canada]: Verzenio (abemaciclib) [PDF]
Eli Lilly Canada Inc., April 2019
7. TGA press release: International Work-sharing Initiative - Abemaciclib (Verzenio).
Cited 09/04/2019
First line treatment - In combination with an aromatase inhibitor
Postmenopausal women with untreated HR-positive, HER2-negative advanced or metastatic breast cancer.
The Food and Drug Administration (FDA), USA, approval of Verzenio (abemaciclib) in combination with an aromatase inhibitor (anastrozole or letrozole) for the treatment of patients with previously untreated HR+/HER- advanced or metastatic breast cancer was based on MONARCH-3, a randomized, double-blinded, placebo-controlled, multicenter study1. This study involved a total of 493 patients who were randomly assigned to one of two groups and received either placebo plus letrozole or anastrozole, or Verzenio (abemaciclib) plus letrozole or anastrozole. Physicians were free to decide whether letrozole or anastrozole was to be taken1.
Results
Among the efficacy outcome measures were the progression-free survival (PFS) and objective response rate (ORR) for patients with measurable disease1.
The combination of Verzenio (abemaciclib) plus letrozole or anastrozole resulted in better results than placebo plus letrozole or anastrozole1.
The median PFS was1:
-
28.2 months [95% CI: 23.5, not reached] with Verzenio (abemaciclib) plus letrozole or anastrozole
-
14.8 months [95% CI: 11.2, 19.2] placebo plus letrozole or anastrozole.
The ORR for patients with measurable disease was1:
-
55.4% [95% CI: 49.5, 61.4] with Verzenio (abemaciclib) plus letrozole or anastrozole
-
40.2% [95% CI: 31.8, 48.5] with placebo plus letrozole or anastrozole.
Second line treatment - In combination with fulvestrant
Patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression on or after prior adjuvant or metastatic endocrine therapy.
The Food and Drug Administration (FDA), USA, approval of Verzenio (abemaciclib) in combination with fulvestrant for the treatment of patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression on or after prior adjuvant or metastatic endocrine therapy was based on MONARCH 2, a randomized, placebo-controlled, multicenter study1. This study involved a total of 669 patients with a median age of 60 years (range, 32-91 years), and 37% of patients were older than 651. Patients were randomly assigned to one of two groups and received either Verzenio (abemaciclib) plus fulvestrant, or placebo plus fulvestrant. Patients remained on continuous treatment until development of progressive disease or unmanageable toxicity1.
Results
Among the efficacy outcome measures were the progression-free survival (PFS) and the objective response rate (ORR).
The median PFS was1:
-
16.4 months [95% CI: 14.4, 19.3] with Verzenio (abemaciclib) plus fulvestrant
-
9.3 months [95% CI: 7.4, 12.7] with placebo plus fulvestrant.
The ORR was1:
-
48,1% with Verzenio (abemaciclib) plus fulvestrant
-
35% with placebo plus fulvestrant.
Second or third line treatment - Monotherapy
Patients with HR-positive, HER2-negative breast cancer who received prior endocrine therapy and 1-2 chemotherapy regimens in the metastatic setting.
The Food and Drug Administration (FDA), USA, approval of Verzenio (abemaciclib) as a monotherapy in metastatic breast cancer patients with HR-positive, HER2-negative breast cancer whose disease progressed during or after endocrine therapy, had received taxane in any setting, and 1-2 chemotherapy regimens in the metastatic setting, was based on MONARCH 1, a single-arm, open-label, multicenter study1. A total of 132 patients received 200 mg VERZENIO orally twice daily on a continuous schedule until development of progressive disease or unmanageable toxicity1. MONARCH-1 was a single arm study, which means that Verzenio (abemaciclib) was not tested against any other medicine. The median duration of metastatic disease was 27.6 months1. Ninety percent (90%) of patients had visceral metastases, and 51% of patients had 3 or more sites of metastatic disease1.
Results
-
Among the efficacy outcome measures were the objective response rate (ORR) and the median duration of response (mDoR)1.
The ORR in MONARCH 1 was1:
-
19,7% [95% CI: 13.3, 27.5] as assessed by an investigator assessed
-
17.4% [95% CI: 11.4, 25] as assessed by an independent reviewer.
The mDoR in MONARCH 1 was1:
-
8.6 months [95% CI: 5.8, 10.2] as assessed by an investigator
-
7.2 months [95% CI: 5.6, not reached] as assessed by an independent reviewer.
References
1. Highlights of Prescribing Information: Verzenio:(abemaciclib).
Eli Lilly and Company. February 2018
Verzenio/Verzenios (abemaciclib) price in other currencies*
| Package | Euro | Australian dollars | Canadian dollar | New Zealand dollar | Nigerian naira | Singapore dollar | Pound sterling | United States dollar |
|---|---|---|---|---|---|---|---|---|
| 28 tablets of 50 mg | 1409 EUR | 2281 AUD | 2076 CAD | 2527 NZD | 2497752 NGN | 1995 SGD | 1174 GBP | 1486 USD |
| 28 tablets of 100 mg | 1409 EUR | 2281 AUD | 2076 CAD | 2527 NZD | 2497752 NGN | 1995 SGD | 1174 GBP | 1486 USD |
| 28 tablets of 150 mg | 1409 EUR | 2281 AUD | 2076 CAD | 2527 NZD | 2497752 NGN | 1995 SGD | 1174 GBP | 1486 USD |
| 56 tablets of 50 mg | 2916 EUR | 4720 AUD | 4296 CAD | 5229 NZD | 5167999 NGN | 4129 SGD | 2430 GBP | 3075 USD |
| 56 tablets of 100 mg | 2916 EUR | 4720 AUD | 4296 CAD | 5229 NZD | 5167999 NGN | 4129 SGD | 2430 GBP | 3075 USD |
| 56 tablets of 150 mg | 2916 EUR | 4720 AUD | 4296 CAD | 5229 NZD | 5167999 NGN | 4129 SGD | 2430 GBP | 3075 USD |
*The prices listed above are based on the cheapest package size and strength everyone.org has access to. Please make an enquiry for more specific pricing. The prices listed above are a guide only, we operate in Euros.
Verzenio/Verzenios (abemaciclib) treatment costs
The cost for a monthly or yearly treatment of Verzenio/Verzenios (abemaciclib) depends on your prescription requirements which includes the dosage in g/mg/ml/etc and medicine type (Tablets).
The price of the medicines you see on sale is the cost set by the manufacturer. In addition, shipping costs and a Named Patient support fee will apply.
Make an enquiry and we will help you calculate the total price to buy Verzenio/Verzenios (abemaciclib) online and have it delivered where you live. From your side, we’ll simply need a prescription from your treating doctor. In some countries we might also need an import license. Our Patient Support team will guide you throughout the process.
Verzenio/Verzenios (abemaciclib) price and additional costs
The price of Verzenio/Verzenios (abemaciclib)
The base cost of each medicine is set by the manufacturer. Generally, our Named Patient support fee, shipping costs and any local tax (if applicable) are not included in the product price that is displayed on our website unless stated otherwise.
Our Named Patient support fee
everyone.org provides access to Verzenio/Verzenios (abemaciclib) on the Named Patient import basis, which means that we work on behalf of the patient in cooperation with their treating doctor. Our Named Patient support fee covers sourcing, logistics and following up to make sure that the order is received safely and in perfect condition. The Named Patient support fee is tiered relative to the cost of the medicine.
Shipping costs
The shipping prices are dependent on the type of shipping necessary for the particular medicine (regular or cold chain) and upon the destination country. The shipping fees may include the shipping from our supplier to our partner pharmacy as well as the shipping costs to deliver the medicine to the patient’s country of residence. The shipping fee might also include the cost of special packaging, such as coolboxes, cool packs and data loggers, as well as transport insurance to guarantee that you receive your medicine in good order.
You can read a detailed overview of prices and costs here.
Payment methods when you buy Verzenio/Verzenios (abemaciclib)
When you buy Verzenio/Verzenios (abemaciclib), you can make the payment by bank transfer or by credit card. Payments are fully encrypted and secure. When paying by credit card, you can pay online once you have received your order confirmation. Please be aware that a 2.8% fee applies when paying by credit card.
Verzenio/Verzenios (abemaciclib) reimbursement
It might be possible for you to claim the cost of Verzenio/Verzenios (abemaciclib) via your country's healthcare system. Some countries have a government fund providing financial assistance for citizens to access lifesaving medical treatment abroad. The best thing would be to check with your country's own health ministry. We also highly recommend checking out local patient blogs, communities and patient organisations to find out more about your options.
Medical insurance
Generally, we do not support medical insurance, but we do provide you with an invoice after you make the payment that you may send to your medical insurance company so they can reimburse you. In some limited circumstances, we do accept insurance. Contact us for more details. You can pay by bank transfer or credit card.
Crowdfunding
Crowdfunding might also be an option for you. It is a means of raising funds by using an online platform to group together many small donations from friends, family and others, in order to help you afford medical treatment. Here are some crowdfunding platforms where you can seek support: GoFundMe, GiveForward, FundRazr and Watsi.
Room temperature shipping
For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.
Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order.
Our standard delivery time varies from 5 to 10 working days.
The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.
You can also pick up your medicine from our partner pharmacy in Amsterdam or our partner pharmacy in Luxembourg after the order has been paid for.
Four steps to access the medicines you need
How and where to access and buy Verzenio/Verzenios: You can access Verzenio/Verzenios from everyone.org if the drug has not been approved or is not available in your country.
-
Step 1
You send a request for your medicine online
Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.
-
Step 2
We verify your prescription and medical details
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.
-
Step 3
We source your medicine
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.
-
Step 4
We deliver your medicine
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine. We will work hard to keep you informed at every step along the way and get your medicine to you quickly and safely. To date we have successfully delivered packages to over 75 countries around the world.
We are highly rated by our patients
Download your free guide on importing medicines into your country.
Provide your email below to receive a step-by-step guide to safely and legally importing medicines unavailable in your country.
Thank you!
You will receive an email with a download link to your guide (or a confirmation if you selected Other) at [email protected]. Please check your spam or junk folder.
Back to pageLet us help you
If you have any questions or need help, we're a phone call away. Our team is available from Monday to Friday between 9 a.m and 6 p.m CET
We usually respond to emails within 24 working hours
Call 
Email About us
We’re a dedicated team of medicine access experts, doctors and pharmacists. We come from all over the world. And we’ve lost family and friends who could not get the medicine they needed because they lived in the wrong country.
Our mission is to get everyone the right treatment at the right time. Wherever you live. Because you should not suffer or die if a treatment that could help you exists somewhere.
Learn moreAbout us
Learn how to access medicines
Learn moreFrequently Asked Questions
Read moreCompare medicines by disease
Disclaimer
We do our best to ensure the accuracy, currency, and completeness of the information provided here, but we can't guarantee it. Medicine information can change over time. The absence of a warning for a given medicine or combination of medicines should not be interpreted as confirmation that it’s safe, effective, or suitable for every patient. Always talk to your treating doctor before starting any treatment.
Worldwide Delivery
Click on a country below to view a guide on how to import medicine into that country.
